Glucose Production and Market in China

Glucose Production and Market in China
  • Report price : $ 3 500
  • Publication date : December 2003
  • Length : 115 pages

Get this Report Now !

Glucose Production and Market in China

The report is a preliminary study on Glucose industry in China. The production, producers, demand & consumption, end-use segments and import & export are introduced plus a brief summary of corn starch industry and glucose history development. Especially, more than 40 producers, breakdown by active, idled, stopped, potential, are profiled from the aspects of background information, product information, capacity, export situation, etc. We have found that: Glucose market is large and most developed in China. The quality of Chinese glucose has been improved to meet the international standard.

It is a trend that some large manufacturers, including the joint ventures in China, become increasingly dominating the Chinese production.

More and more minor producers will stop production in the future. For those small-scale factories, the production cost is higher than that of large scale producers. In order to reduce cost and improve competitiveness, domestic producers keep on expanding their production capacity but not paying enough attention to the domestic demand.

In China, oral grade glucose production is not a profitable business and the survival of the future players depends on the production scale and the fame around the country.

It seems that injection grade glucose will be promising in the future due to its relatively high consumption capability in China, especially for anhydrous glucose.

As to industrial grade powder glucose, its demand is not large and it has little added value. It is falling into disuse.

In respect to application, China is a large potential market to tap, especially in the field of candy, beverage, pharmaceutical and downstream products.




Shandong Xiwang Group Co., Ltd, Hebei Qinhuangdao Lihua Starch Co., Ltd., Hebei Shijiazhuang Huaying United Factory, Shandong Weifang Shengtai Medicine Co., Ltd., Shandong Lianmeng Chemical Group Co., Ltd., etc.

RELATED REPORTS

Production and Market of Anhydrous Dextrose in China

Production and Market of Anhydrous Dextrose in China

  • $ 2 500
  • December 2005
  • 31 pages

The aim of this report is to provide basic understanding to the Chinese anhydrous dextrose industry. This report is presented in two parts. The part of production & market information, discusses & summarises the production situation in China from aspects of past production situation, present product ...

Industries : Pharmaceutical | Countries : China

The Paracetamol Industry in China

The Paracetamol Industry in China

  • $ 8 000
  • March 2006
  • 196 pages

Paracetamol, the active ingredient that contained in more than 100 natural herbs, was found by Morse in 1878 and was first used in clinically by Von Mering in 1893. In China, paracetamol has been in used as an analgesic for over 30 years and has been accepted as a very effective drug to relief pain ...

Industries : Pharmaceutical | Countries : China

Ephedrine Production & Market in China

Ephedrine Production & Market in China

  • $ 5 000
  • March 2006
  • 152 pages

There have been new changes to China’s ephedrine industry in recent three years (2004~2006), in output, production method and government's role, etc. In the coming several years, how will the ephedrine industry in China go? You can find the answers after reading this report. The report thoroughly ...

Industries : Pharmaceutical | Countries : China

Aspirin Production & Market in China

Aspirin Production & Market in China

  • $ 3 500
  • April 2006
  • 112 pages

The report aims to uncover the situation of aspirin in China from aspects of production, import & export, consumption, manufacturers and technology. The report focuses on the bulk aspirin, but the major preparations are also introduced. In addition, the overview of analgesic-antipyretic industry and ...

Industries : Pharmaceutical | Countries : China

Benchmarking on Paracetamol and para-Amino Phenol (PAP) Production in China

Benchmarking on Paracetamol and para-Amino Phenol (PAP) Production in China

  • $ 12 000
  • June 2006
  • 92 pages

In the past ten years, Chinese paracetamol industry developed quickly, its output, export and domestic consumption all increased by over 10%. At the same time, PAP output in China grew quickly with a CAGR of 16.38%. What’s the production cost in China’s paracetamol and PAP producers? What consti ...

Industries : Pharmaceutical | Countries : China

China Retail Pharmacies

China Retail Pharmacies

  • $ 5 000
  • September 2008
  • 90 pages

China Independent Retail Pharmacies is provides a comprehensive and in-depth examination of the independent and chain drugstore sector in China. Areas of focus include the changing regulatory landscape, business practices and sales models of successful pharmacies, key market drivers and players, an ...

Industries : Pharmaceutical | Countries : China

China Antibodies

China Antibodies

  • $ 2 000
  • April 2007
  • 42 pages

With a rapidly growing economy, cost advantages, a skilled workforce, and a governmental commitment to the sciences, China is becoming increasingly important in the global biotechnology industry. Successful forays into high technology manufacturing and the increasing prestige of its scientific insti ...

Industries : Pharmaceutical | Countries : China

China Preclinical Services

China Preclinical Services

  • $ 1 000
  • August 2005
  • 64 pages

As the China services industry gains experience, its ability to perform services for the global market while striving to meet international standards has made it a growing presence in preclinical development. Today, leading companies are taking advantage of the opportunities that China presents.Chin ...

Industries : Pharmaceutical | Countries : China

China Vaccine

China Vaccine

  • $ 5 000
  • December 2007
  • 72 pages

China Vaccine 2008 provides an in depth analysis of the human use vaccine industry and market in China. The markets analysis covers the private payer sector, as well as providing an in depth look at the National Immunization Program, and the impact of the 10-fold increase in budget announced in 2007 ...

Industries : Pharmaceutical | Countries : China

China Molecular Diagnostics

China Molecular Diagnostics

  • $ 5 000
  • January 2008
  • 80 pages

China Molecular diagnostics in a high growth, high profit, high investment area in China. Industry players, investors, buyers, and vendors will benefit from this essential database. This database includes more than 100 companies providing molecular diagnostic products and services in China. More tha ...

Industries : Pharmaceutical | Countries : China

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.